Jim Cramer Blog

Discuss Hot Stocks, Jim Cramer, Mad Money,the Stock and Option Markets, and the economy on Jim Cramer Blog.

Saturday, September 30, 2006

Acorda Therapeutics (ACOR) Stock Upgraded

Acorda Therapeutics (NASDAQ:ACOR - News) was upgraded to outperform from market perform at Piper Jaffray. The firm also lifted its price target on the stock to $14 from $6.50, citing physician consultants' consensus opinion that Fampridine-SR offers modest but broad clinical benefit.

posted by Stock Administrator @ 3:56 PM  

0 Comments:

Post a Comment

<< Home

This site is not affiliated with Mr. James Cramer, and is not associated with any television networks or broadcasts. Data presented on this site should not be used to make investment decisions and accuracy cannot be guaranteed GRB Holding Co., LLC

;